Gut-directed hypnotherapy for IBS-M: evidence review
Mixed IBS is well represented in GDH trials as part of the global-symptom evidence. Dedicated IBS-M endpoints are scarce.
Last reviewed 27 August 2026
Mixed-stool IBS (IBS-M) is common in clinic and in older trial samples that did not split subtypes cleanly. Global improvement data apply, but “less switching” is rarely a primary outcome.
Key evidence
Treat the programme-level evidence as the main signal. Subtype pages exist so we do not pretend IBS-D, IBS-C, and IBS-M are equally measured.
Limitations
Rome IV mixed criteria are newer than much of the Manchester literature.
What we don't know yet
Whether GDH reduces subtype switching is not established.
This page is informational only. It is not personal medical advice.

Reviewed by
Rebecca SmithDip.Clin.Hyp. Women's Health Specialist
